Trials / Recruiting
RecruitingNCT07142265
Evaluation of 1-Year Clinical Outcomes With Early Inclisiran Initiation in Post-MI Patients
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of clinical outcomes during 12 months after inclisiran initiation in patients after STEMI/non-STEMI in real-world settings in Russia. It is also planned to study the therapy effect on the lipid profile characteristics, its safety, the state of atherosclerotic plaques according to carotid ultrasound, the frequency of hospitalizations and the need for intensive follow-up.
Conditions
Timeline
- Start date
- 2025-09-30
- Primary completion
- 2027-09-30
- Completion
- 2027-09-30
- First posted
- 2025-08-26
- Last updated
- 2026-04-16
Locations
13 sites across 1 country: Russia
Source: ClinicalTrials.gov record NCT07142265. Inclusion in this directory is not an endorsement.